← FDA DRUG APPROVALS

FDA ANDA · ANDA218840

CALCIUM GLUCONATE

Sponsor: CAPLIN

APPLICATION
ANDA218840
TYPE
ANDA
ORIGINAL APPROVAL
2026-05-04
LATEST ACTION
2026-05-04
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

CALCIUM GLUCONATEPrescription
CALCIUM GLUCONATE 5GM/50ML (100MG/ML) · SOLUTION · INTRAVENOUS
CALCIUM GLUCONATEPrescription
CALCIUM GLUCONATE 10GM/100ML (100MG/ML) · SOLUTION · INTRAVENOUS
CALCIUM GLUCONATEPrescription
CALCIUM GLUCONATE 1GM/10ML (100MG/ML) · SOLUTION · INTRAVENOUS

Approval history

2026-05-04UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →